Maxygen's Unattributed VC Round

Maxygen raised a round of funding on April 17, 1998.

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs. The company's lead program, MAXY-G34, is designed to be an improved version of long-acting G-CSF for th…

Articles about Maxygen's Unattributed VC Round: